SCP-2712
Safe
~
medium confidence
SCP-2712
Expected annual
$2.5M
One-time setup
$2.5M
Annual recurring
$2.4M
Personnel
12
Estimated one-time setup of $2,520,000 driven by AO#7130 repair, secure servers, and test/containment buildout; ongoing annual costs of $2,381,250 driven primarily by staff wages for a dedicated research/response team, long-term restoration/reintegration care, cybersecurity, and maintenance.
One-Time Capital Costs
Total: $2.5M
Annual Recurring Costs
Total: $2.4M/yr
Cost Scenarios
📊
Baseline
(baseline)
$2.4M/yr
Normal year with no major incidents: ongoing operations, daily reads, routine maintenance, and monitoring.
routine_operations
no_major_incident
🚨
Minor Incident
$2.5M/yr
Small incident or anomalous behavior requiring incident response, audits, and limited restoration actions.
transient_anomalous_behavior
small_data_leak
limited_emergency_response
🚨
Active Restoration Campaign
$3.9M/yr
Full-scale restoration campaign: AO#7130 repair efforts, expanded research team deployment, prolonged clinical trials and higher operational tempo.
decision_to_run_full_AO_repair
major_clinical_trials
extended_research_deployment
Personnel
12 total
| Role | Count | Notes |
|---|---|---|
| Level-4 Reader | 3 | Roster of three Level-4+ employees to ensure daily reading coverage (aggregates to ~0.3 FTE cost allocation) [#4]. |
| Research Scientist (senior) | 3 | Senior researchers specializing in memetics/infosci/neural interfaces forming core restoration team [#5]. |
| Engineer / Maintenance | 2 | Engineers for AO#7130 repair, experimental apparatus, and hardware [#5, #6]. |
| Technician | 2 | Technicians to support experiments, instrumentation, and repairs [#5, #17]. |
| Ethics / Legal Liaison | 1 | Ethics/legal liaison for clinical approvals, family communications, and cover-story coordination [#5, #12]. |
| Sysadmin / Database Admin | 1 | Part-time sysadmin to maintain SCP database entries, replication, and access controls (~0.1–0.3 FTE cost represented in staff wages) [#21]. |
Confidence Notes
Analyst notes provide ranges for nearly every line item, enabling mid-point estimates; however key uncertainties remain (AO#7130 repair complexity, clinical trial scope, and long-term outcomes), so overall confidence is medium.